Pulmonary Infections and Risk of Lung Cancer Among Persons with AIDS

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2010 Aug 26

PMID 20736841

Citations 36

Authors

Fatma M Shebl

Eric A Engels

James J Goedert

Anil K Chaturvedi

Affiliations

Soon will be listed here.

Abstract

Lung cancer risk is significantly increased among persons with AIDS (PWA), and increased smoking may not explain all of the elevated risk, suggesting a role for additional cofactors. We investigated whether AIDS-defining pulmonary infections (recurrent pneumonia, Pneumocystis jirovecii pneumonia, and pulmonary tuberculosis) affected the risk of subsequent lung cancer over 10 years after AIDS onset among 322,675 PWA, whose records were linked with cancer registries in 11 US regions. We assessed lung cancer hazard ratios (HRs) using Cox regression and indirectly adjusted HRs for confounding by smoking. Individuals with recurrent pneumonia (n = 5317) were at significantly higher lung cancer risk than those without [HR = 1.63, 95% confidence interval (CI) = 1.08 to 2.46, adjusted for age, race, sex, HIV acquisition mode, CD4 count, and AIDS diagnosis year]. This association was especially strong among young PWA (<50 years HR = 1.99 vs. ≥50 years HR = 1.10) and was significantly elevated during 5-10 years after recurrent pneumonia diagnosis (HR = 2.41; 95% CI = 1.07 to 5.47). Although attenuated, HRs for recurrent pneumonia remained nonsignificantly elevated after indirect adjustment for smoking. Lung cancer risk was unrelated to tuberculosis [(n = 13,878) HR = 1.12, 95% CI = 0.82 to 1.53] or Pneumocystis jirovecii pneumonia [(n = 69,771) HR = 0.97, 95% CI = 0.80 to 1.18]. The increased lung cancer risk associated with recurrent pneumonia supports the hypothesis that chronic pulmonary inflammation arising from infections contributes to lung carcinogenesis.

Citing Articles

Sequelae of Immunocompromised Host Pneumonia.

Salwen B, Mascarenhas E, Horne D, Crothers K, Zifodya J Clin Chest Med. 2025; 46(1):49-60.

PMID: 39890292 PMC: 11790256. DOI: 10.1016/j.ccm.2024.10.004.

HIV-associated lung disease.

Konstantinidis I, Crothers K, Kunisaki K, Drummond M, Benfield T, Zar H Nat Rev Dis Primers. 2023; 9(1):39.

PMID: 37500684 PMC: 11146142. DOI: 10.1038/s41572-023-00450-5.

CT imaging of HIV-associated pulmonary disorders in COVID-19 pandemic.

Abuladze L, Blokhin I, Gonchar A, Suchilova M, Vladzymyrskyy A, Gombolevskiy V Clin Imaging. 2023; 95:97-106.

PMID: 36706642 PMC: 9846904. DOI: 10.1016/j.clinimag.2023.01.006.

Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.

Haas C, Engels E, Horner M, Freedman N, Luo Q, Gershman S Lancet HIV. 2022; 9(10):e700-e708.

PMID: 36179753 PMC: 9641618. DOI: 10.1016/S2352-3018(22)00219-3.

Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.

Sirera G, Videla S, Saludes V, Castella E, Sanz C, Ariza A Sci Rep. 2022; 12(1):13196.

PMID: 35915124 PMC: 9343353. DOI: 10.1038/s41598-022-17237-5.

References

Mayne S, Buenconsejo J, Janerich D . Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999; 149(1):13-20. DOI: 10.1093/oxfordjournals.aje.a009722. View

Grau I, Pallares R, Tubau F, Schulze M, Llopis F, Podzamczer D . Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005; 165(13):1533-40. DOI: 10.1001/archinte.165.13.1533. View

Engels E, Pfeiffer R, Goedert J, Virgo P, McNeel T, Scoppa S . Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006; 20(12):1645-54. DOI: 10.1097/01.aids.0000238411.75324.59. View

Liang H, Li X, Yu X, Guan P, Yin Z, He Q . Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009; 125(12):2936-44. DOI: 10.1002/ijc.24636. View

Jemal A, Travis W, Tarone R, Travis L, Devesa S . Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer. 2003; 105(1):101-7. DOI: 10.1002/ijc.11020. View

Engels E, Shen M, Chapman R, Pfeiffer R, Yu Y, He X . Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. Int J Cancer. 2008; 124(5):1183-7. PMC: 2610239. DOI: 10.1002/ijc.24042. View

Caiaffa W, Graham N, Vlahov D . Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol. 1993; 138(11):909-22. DOI: 10.1093/oxfordjournals.aje.a116812. View

Engels E, Brock M, Chen J, Hooker C, Gillison M, Moore R . Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006; 24(9):1383-8. DOI: 10.1200/JCO.2005.03.4413. View

Morris A, Huang L, Bacchetti P, Turner J, Hopewell P, Wallace J . Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):612-6. DOI: 10.1164/ajrccm.162.2.9912058. View

10.

Chaturvedi A, Pfeiffer R, Chang L, Goedert J, Biggar R, Engels E . Elevated risk of lung cancer among people with AIDS. AIDS. 2007; 21(2):207-13. DOI: 10.1097/QAD.0b013e3280118fca. View

11.

Kirk G, Merlo C, O Driscoll P, Mehta S, Galai N, Vlahov D . HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45(1):103-10. PMC: 4078722. DOI: 10.1086/518606. View

12.

Diaz P, King M, Pacht E, Wewers M, Gadek J, Nagaraja H . Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000; 132(5):369-72. DOI: 10.7326/0003-4819-132-5-200003070-00006. View

13.

Tamura A, Hebisawa A, Iuchi K, Maeda H, Fukai S, Komatsu H . Lung cancer in patients with chronic pyothorax. Respirology. 2008; 13(4):585-9. DOI: 10.1111/j.1440-1843.2008.01281.x. View

14.

Hirschtick R, Glassroth J, Jordan M, Wilcosky T, Wallace J, Kvale P . Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995; 333(13):845-51. DOI: 10.1056/NEJM199509283331305. View

15.

Guiguet M, Boue F, Cadranel J, Lang J, Rosenthal E, Costagliola D . Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009; 10(12):1152-9. DOI: 10.1016/S1470-2045(09)70282-7. View

16.

Engels E . Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008; 8(4):605-15. DOI: 10.1586/14737140.8.4.605. View

17.

Wu A, Fontham E, Reynolds P, Greenberg R, Buffler P, Liff J . Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995; 141(11):1023-32. DOI: 10.1093/oxfordjournals.aje.a117366. View

18.

. Impact of the expanded AIDS surveillance case definition on AIDS case reporting--United States, first quarter, 1993. MMWR Morb Mortal Wkly Rep. 1993; 42(16):308-10. View

19.

Ramanakumar A, Parent M, Menzies D, Siemiatycki J . Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer. 2006; 53(1):5-12. DOI: 10.1016/j.lungcan.2006.04.007. View

20.

Thun M, Apicella L, Henley S . Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA. 2000; 284(6):706-12. DOI: 10.1001/jama.284.6.706. View